Eris Lifesciences Board Meeting on Oct 26 for Q2 FY27 Results

Eris Lifesciences Limited has announced a Board of Directors meeting scheduled for Monday, October 26, 2026. The primary agenda is to consider and approve the standalone and consolidated unaudited financial results for the quarter and half-year ended September 30, 2026. The company has also informed that the trading window for designated persons and their relatives has been closed from October 01, 2026, and will reopen 48 hours after the declaration of these financial results, in compliance with SEBI regulations.